AKOS BBS-00000983
- $306 - $1160
- Product name: AKOS BBS-00000983
- CAS: 868212-21-9
- MF: C8H9NO4S
- MW: 215.23
- EINECS:
- MDL Number:MFCD06496454
- Synonyms:IFLAB-BB F1742-0051;AKOS BBS-00000983;(3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid;5-Thiazolidineacetic acid, 2,4-dioxo-3-(2-propen-1-yl)-
4 prices
Selected condition:
Brand
- ACHEMBLOCK
- Matrix Scientific
Package
- 1g
- 2.500g
- 5G
- ManufacturerACHEMBLOCK
- Product numberL19329
- Product description(3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)aceticacid 95%
- Packaging5G
- Price$1160
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number136058
- Product description(3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+
- Packaging1g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number136058
- Product description(3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+
- Packaging2.500g
- Price$666
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number136058
- Product description(3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+
- Packaging5g
- Price$1010
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ACHEMBLOCK | L19329 | (3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)aceticacid 95% | 5G | $1160 | 2021-12-16 | Buy |
Matrix Scientific | 136058 | (3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+ | 1g | $306 | 2021-12-16 | Buy |
Matrix Scientific | 136058 | (3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+ | 2.500g | $666 | 2021-12-16 | Buy |
Matrix Scientific | 136058 | (3-Allyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid 95%+ | 5g | $1010 | 2021-12-16 | Buy |
Properties
Boiling point :397.2±44.0 °C(Predicted)
Density :1.401±0.06 g/cm3(Predicted)
pka :3.78±0.10(Predicted)
Density :1.401±0.06 g/cm3(Predicted)
pka :3.78±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|